Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post–Myocardial Infarction Remodeling
Autor: | Kia N. Zellars, Eva Romito, Heather Doviak, Tae-Weon Lee, Gregory L. Brower, Parker D. Freels, Stephen W. Smith, David C Lobb, James A Shuman, Lisa A. Freeburg, Francis G. Spinale, Aarif Y. Khakoo, Jason W. O’Neill |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Myocardial Infarction Inflammation Pharmacology Matrix metalloproteinase Cardiovascular Injections Biological pathway 03 medical and health sciences 0302 clinical medicine Protein Domains In vivo Humans Medicine Amino Acid Sequence RNA Messenger Myocardial infarction Tissue Inhibitor of Metalloproteinase-3 Ejection fraction Ventricular Remodeling business.industry Tissue inhibitor of metalloproteinase medicine.disease Matrix Metalloproteinases Peptide Fragments 030104 developmental biology Gene Expression Regulation Cytokines Molecular Medicine Tumor necrosis factor alpha Collagen medicine.symptom business 030217 neurology & neurosurgery |
Zdroj: | J Pharmacol Exp Ther |
ISSN: | 1521-0103 0022-3565 |
Popis: | Infarct expansion can occur after myocardial infarction (MI), which leads to adverse left ventricular (LV) remodeling and failure. An imbalance between matrix metalloproteinase (MMP) induction and tissue inhibitors of MMPs (TIMPs) can accelerate this process. Past studies have shown different biologic effects of TIMP-3, which may depend upon specific domains within the TIMP-3 molecule. This study tested the hypothesis that differential effects of direct myocardial injections of either a full-length recombinant TIMP-3 (F-TIMP-3) or a truncated form encompassing the N-terminal region (N-TIMP-3) could be identified post-MI. MI was induced in pigs that were randomized for MI injections (30 mg) and received targeted injections within the MI region of F-TIMP-3 (n = 8), N-TIMP-3 (n = 9), or saline injection (MI-only, n = 11). At 14 days post-MI, LV ejection fraction fell post-MI but remained higher in both TIMP-3 groups. Tumor necrosis factor and interleukin-10 mRNA increased by over 10-fold in the MI-only and N-TIMP-3 groups but were reduced with F-TIMP-3 at this post-MI time point. Direct MI injection of either a full-length or truncated form of TIMP-3 is sufficient to favorably alter the course of post-MI remodeling. The functional and differential relevance of TIMP-3 domains has been established in vivo since the TIMP-3 constructs demonstrated different MMP/cytokine expression profiles. These translational studies identify a unique and more specific therapeutic strategy to alter the course of LV remodeling and dysfunction after MI. SIGNIFICANCE STATEMENT: Using different formulations of tissue inhibitor of matrix metalloproteinase-3 (TIMP-3), when injected into the myocardial infarction (MI) region, slowed the progression of indices of left ventricular (LV) failure, suggesting that the N terminus of TIMP-3 is sufficient to attenuate early adverse functional events post-MI. Injections of full-length recombinant TIMP-3, but not of the N-terminal region of TIMP-3, reduced relative indices of inflammation at the mRNA level, suggesting that the C-terminal region affects other biological pathways. These unique proof-of-concept studies demonstrate the feasibility of using recombinant small molecules to selectively interrupt adverse LV remodeling post-MI. |
Databáze: | OpenAIRE |
Externí odkaz: |